Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : XOMA. Bull or Bear? -- Ignore unavailable to you. Want to Upgrade?

To: aknahow who wrote (10054)	5/18/1999 10:30:00 AM
From: Bluegreen	Read Replies (2) \| Respond to of 17367

George, they haven't even told us whether or not mortality "requirement" was met.

To: aknahow who wrote (10054)	5/18/1999 6:25:00 PM
From: Cacaito	Read Replies (1) \| Respond to of 17367

George w, Recruits are follow up for 90 days for Neurobahavioral evaluation, the it could be unblinded. If unblinding before the neurological evaluation happens, then that part of study is not blind and damage. UNLESS it was built up in the original design that the Neuroevaluators will do their job so completely independent that the unblinding could happen for one set of data and not for the other. I do not think that is the case. Data leak will be minimal to Zero. Speculators will build up as dateline approaches. Nothing certain, believers are not to be followed. It is not a question of faith, it is a question of fact. Please, wait for the fact. Do not invest more. Stay away in the wait. Those who enter after announcement will triple their money OR save a bunch.